C18orf12

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, C18orf12 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of C18orf12’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where C18orf12 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types C18orf12 is over-expressed in tumor.

BLCA are the cancer types where C18orf12 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in C18orf12 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
BLCAAllAll+0.102.0462view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

C18orf12–BLCA

Tumor-vs-normal expression box plot for C18orf12 RNA in BLCA.

Open the BLCA breakdown →

Exploration